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Objective: To assess prevalence of cyclical mastalgia and its main determinants in
women who attended in health centers of Hamadan City, Iran.
Methods: This case–control study was conducted on 400 women (case: cyclical mas-
talgia, n = 240; control: without cyclical mastalgia, n = 160) who attended family
planning clinic for routine follow-up in health centers. The cluster sampling was used.
Information was collected by interviewing and using a standardized validated question-
naire. Severity of mastalgia was assessed through using visual analog scaling. Data
processing and statistical analysis were performed by using SPSS 19.0.
Results: The results revealed thatmajority ofwomen (60.0%) experienced cyclicalmastalgia.
Out of these, 22.5% and 37.5%were mild and moderate-to-severe mastalgia, respectively. No
association was revealed in experience of depression and anxiety in mastalgia group. In a
multivariable logistic regressionmodel, the increasing age, age ofmarriage, history of abortion
and history of premenstrual syndrome were main determinants of mastalgia, while use of oral
contraceptive and regular exercise was associated with lower incidence of mastalgia.
Conclusions: Most of women with breast discomfort suffered cyclical mastalgia which
severity can be determined by advanced age, age of marriage, history of abortion and history
of premenstrual syndrome, but inversely by oral contraceptive use and exercise activity.1. Introduction
Cyclical mastalgia affects up to two-thirds of women at some
time during their reproductive lives. It is usually benign, but the
fear of underlying breast cancer has become one of the most
frequent reasons for consultation. Cyclic mastalgia is a common
symptom experienced by women of reproductive age. It may be
caused by the normal monthly changes in hormones. This pain
usually occurs in both breasts. The pain is usually the most
severe before a menstrual period and is often relieved when this
period ends. Most cyclic pain relieves without treatment and
usually disappears at menopause [1]. In most of the women whosuffered from this phenomenon, reassurance is the only advice
required because of its self-limited nature emerging gradually
and spontaneously within a few months. However, in some of
them, suggesting different types of lifestyles such as adopting
regular exercise, weight reduction, modifying dietary regimens,
and quitting smoking should be scheduled [2–4].
The prevalence of this complaint has been widely varied
because of inter-individual differences and social features. The
study by Coskun et al. reported the prevalence of mastalgia in
women attending in breast screening program to be 69% [5]. Amin
et al. also revealed that 30% of premenstrual women suffered from
cyclical mastalgia lasting for more than 5 days a month [6]. In
another report by Ader et al., 68% of women aged 18–44 years
experienced cyclical breast symptoms; 22% experienced
moderate-to-extreme discomfort (classiﬁed as cyclical mastalgia)
[7]. Another report showed that 15% was frequent mastalgia [8].
Mastalgia can be associated with premenstrual syndrome
(PMS), ﬁbrocystic breast disease, psychologic disturbance and,
rarely, breast cancer. The majority of women can be reassured
after a clinical evaluation. Approximately, 15% women with
cyclical mastalgia require pain-relieving therapy. Mechanical
breast support, a low-fat, high-carbohydrate diet and topical non-
steroidal anti-inﬂammatory agents are reasonable ﬁrst-line treat-
ments. Hormonal agents, such as bromocriptine, tamoxifen andarticle under the CC BY-NC-ND license (http://
Figure 1. Distribution of pain severity in mastalgia group.
VAS: Visual analog scaling.
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Sixty percent of cyclic mastalgia recurs after treatment [1,3].
This variation in the prevalence of cyclical mastalgia not only
depends on personal and social characteristics, but also is
dependant to various determinant factors such as smoking, age,
social and physical activities, and even psychological distur-
bances that should be identiﬁed to proper management of this
phenomenon in each population [1]. Besides, because of its
probable association with breast cancer, identifying risk factors
of cyclical mastalgia is necessary.
This study aimed to assess prevalence of cyclical mastalgia
and its main determinants in women who attended in health
centers of Hamadan City, Iran in 2013.
2. Materials and methods
2.1. Study sample
This case–control study was carried out on 400 women aged
15–60 years who attended family planning clinic for routine
follow-up in health centers of Hamadan City, Iran in 2013. The
study included case subjects (n = 240) who had cyclical mas-
talgia. The control subjects (n = 160) were women who did not
have cyclical mastalgia. The cluster sampling was used. Firstly,
the Hamadan City was divided into 4 regions and then from each
region, four health centers were selected. Ten women of each
center who did not have cyclical mastalgia were selected as a
control group and 15 women who had cyclical mastalgia were
selected as a case group. The subjects were chosen randomly
according to their cyclical mastalgia. Inclusion criteria were: age
ranging from 15 to 45 years with a diagnosis of benign breast
disorder (It is generally described as a heaviness or soreness that
radiates to the armpit and arm), not pregnant, not breast feeding;
and the exclusion criteria were: women with age below 15 and
above 45 years, pregnancy, lactation, allergy to drugs, use of
drugs (hormonal, danazol, aspirin and bromocriptine), no pre-
vious history of breast malignancies.
All relevant information was collected by interviewing and
using a standardized validated questionnaire including de-
mographic characteristics, marital state, occupational condition,
anthropometric parameters, educational level, characteristics
related to mastalgia such as its time and duration, characteristics
related to menstrual cycles, results of diagnostic interventions
(breast sonography and mammography), and also previous his-
tory of psychological disorders including depression or anxiety.
Self-reported height and weight were assessed and body mass
index was calculated as weight (kg)/m2. In this study, the
diagnosis of depression and anxiety was made by using the
Diagnostic and Statistical Manual of Mental Disorders IV.
Cyclical mastalgia was deﬁned as a bilateral painful breast
swelling, lasting for more than 4 days and up to 3 weeks, always
preceding menses, and subsiding progressively during
menstruation [9]. Furthermore, severity of mastalgia was
assessed by using visual analog scaling that scored between
0 and 10 and higher scores indicated higher pain severity.
2.2. Ethical considerations
The study was performed according to the Helsinki decla-
ration protocol. The objectives of the study were explained to
the women, and informed consent was obtained from allparticipants. Women could leave the study at any time. The
study was approved by the Ethical Committee of Hamadan
University of Medical Sciences.
2.3. Statistical analysis
Results were reported as mean ± SD for the quantitative
variables and percentages for the categorical variables. The
groups were compared by using the student's t-test for the
continuous variables and the Chi-square test (or Fisher's exact
test if required) for the categorical variables. Multivariate lo-
gistic regression analysis was taken to investigate their inde-
pendence predictors. P-values less than 0.05 were considered
statistically signiﬁcant. Data processing and statistical analysis
were performed by using SPSS version 19.0.
3. Results
The presence of cyclical mastalgia was reported in 60.0% of
studied women. Out of these, 22.5% women had mild and
37.5% moderate-to-severe mastalgia, respectively. In mastalgia
group, average duration of mastalgia was (5.52 ± 3.39) years and
95.8% of them, mastalgia was appeared before menstrual period.
The mean score of mastalgia was 3.22 ± 2.97. Majority of
women (14%) had mastalgia “5” according visual analog scaling
(Figure 1). A summary of women characteristics with or without
mastalgia is shown in Table 1. No signiﬁcant differences were
found as far as marital status, educational level, number of
parity, breast feeding, regularity of menstrual cycles, prevalence
of chronic pelvic pain, family history of breast cancer, body
mass index, age at menarche, as well as duration and interval of
menstrual cycles. With regard to other characteristics, those who
suffered from mastalgia were older, had higher mean marital
age, experienced higher number of abortions, and suffered more
from PMS in comparison with another group. Also, women with
mastalgia expressed to have more regular exercise activity and
have higher experience of breast sonography and mammog-
raphy. Regarding psychological states, no discrepant was
revealed in experience of depression; however anxiety was
slightly more prevalent in mastalgia group. There was also
signiﬁcant difference in method of contraception in which the
use of withdrawal method was more observed in mastalgia
group, while using oral contraceptive (OCP) was more found in
control group (Figure 2).
Table 1
Baseline characteristics and clinical data of study population. n (%).
Characteristics Mastalgia
group
(n = 240)
Non-
mastalgia
group
(n = 160)
P-value
Age (years) 31.03 ± 8.92 28.44 ± 8.10 0.003*
Marriage age
(years)
<20 53 (22.1) 64 (40.0) <0.001*
20 136 (56.7) 75 (46.9) 0.013*
Occupational
state
Worker 95 (39.6) 41 (25.6) 0.062
Housewife 145 (60.4) 119 (74.4) 0.070
Marital status Single 50 (20.8) 26 (16.3) 0.253
Married 190 (79.2) 133 (83.7) 0.061
MBMI
(kg/m2)
22.40 ± 5.33 21.50 ± 5.85 0.111
Educational
level
Primary 29 (12.1) 24 (15.0) 0.073
High
school
38 (15.8) 37 (23.1) 0.056
Higher
degree
173 (72.1) 99 (61.9) 0.063
Number of
parity
2.04 ± 1.09 2.09 ± 1.00 0.669
History of
abortion
40 (16.7) 14 (8.7) 0.042*
Breast feeding 128 (53.3) 100 (62.5) 0.056
Age of
menarche
13.49 ± 1.30 13.44 ± 1.40 0.749
Menstrual
period (days)
6.45 ± 1.49 6.46 ± 1.63 0.938
Regular
menstrual
cycle
187 (77.9) 120 (75.0) 0.499
PMS 193 (80.4) 63 (39.4) <0.001*
Chronic
pelvic pain
33 (13.8) 16 (10.0) 0.262
Family
history of BC
18 (7.5) 11 (6.9) 0.813
Regular
exercise
activity
60 (25.0) 120 (50.0) 0.001*
OCP use 27 (6.70) 42 (10.50) 0.040*
History of
depression
30 (12.5) 20 (12.5) 0.999
History of
anxiety
70 (29.2) 33 (20.6) 0.056
History of BS 44 (18.3) 3 (1.9) <0.001*
History of
mammography34 (14.2)7 (4.4)0.002**: P < 0.05; BC: Breast cancer;
MBMI: Mean body mass index; BS: Breast sonography.
Figure 2. The frequency of method used of contraception in mastalgia and
control groups.
A: OCP; B: DMPA; C: IUD; D: Withdrawal; E: Surgery; F: Kandom; G:
Others.
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and in a multivariable logistic regression model, advanced age,
age of marriage, and history of PMS were main determinants of
mastalgia, while use of OCP was associated with lower inci-
dence of mastalgia (Table 2). Meanwhile, in a multivariate linear
regression analysis, severity of mastalgia was positively related
to high age, high marriage age, history of abortion, suffering
from PMS, whereas it was adversely associated with regular
exercise activity and use of OCP (Table 3).Table 2
Multivariate logistic regression model for determinants of mastalgia.
Item P-value Odds ratio 95% CI
Age 0.010* 1.042 1.010 1.075
Marriage age < 0.001* 1.961 1.357 2.833
History of abortion 0.077 0.496 0.229 1.078
PMS < 0.001* 5.810 3.554 9.498
History of anxiety 0.774 0.923 0.532 1.601
Regular exercise 0.271 1.306 0.812 2.101
OCP use 0.017* 0.449 0.233 0.867
*: P < 0.05.
Table 3
Multivariate linear regression model for determinants of severity of
mastalgia.
Item P-value Beta SE
Age < 0.001* 0.065 0.017*
Marriage age < 0.001* 0.772 0.203
History of abortion 0.005* 1.168 0.415
PMS < 0.001* 2.189 0.280
History of anxiety 0.583 0.166 0.302
Regular exercise 0.048* −0.524 0.264
OCP use 0.001* −1.196 0.373
*: P < 0.05.4. Discussion
According to our ﬁndings, 60.0% of our women suffered from
cyclical mastalgia and in most of them the pain was appeared
before menstrual period. Regarding main indicators of this phe-
nomenon, multivariable regression modeling showed increasing
age, age of marriage, history of abortion and history of PMS were
main determinants of mastalgia, while use of OCP and regular
exercise was associated with lower incidence of mastalgia. No
association was revealed with experience of depression and
anxiety in mastalgia group. While another report showed that
frequent mastalgia is strongly associated with post traumatic
stress disorder and other psychiatric conditions. Clinicians seeing
patients with frequent mastalgia should inquire about anxiety,
depression, alcohol misuse, and trauma history [8,9].
The study by Ader et al. showed that 30% of premenstrual
women suffered from cyclical mastalgia lasting for more than 5
days a month [7], which was of sufﬁcient severity to interfere with
sexual, physical, social and work-related activities. Furthermore,
Brown et al. [10], found the prevalence of mastalgia in women
attending a breast screening program to be 69%. In another
survey, it was reported that 68% of women experienced
cyclical breast symptoms and 22% of these women experienced
moderate-to-extreme discomfort [11]. Hormonal contraceptive
usage was associated with signiﬁcantly less mastalgia and
PMS. While, smoking, caffeine consumption and perceived
stress were associated with mastalgia. Also, younger women
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those without mastalgia (20.2% versus 9.9%). Also, they also
reported in another observation that mastalgia was not
signiﬁcantly associated with PMS so 82% of women with
clinical cyclical mastalgia did not have this syndrome [12]. The
literatures have revealed that in another countries, mastalgia is
a common complaint that may affect up to 70% of women in
their lifetime [13,14]. Interestingly, it is less common in Asian
cultures, affecting as few as 5% [15]. Cyclical mastalgia affects
up to 40% of women before menopause, most often in their
thirties [16]. In approximately 8% of these women had severe
pain which interfered with their normal activities. A minority
of women with the most severe pain experienced it during
menstruation [17]. The pain can continue for many years but
will usually disappear after menopause. Comparing our results
with previous observations in both eastern and western
societies showed that the pattern of cyclical mastalgia in our
community is following similar patterns in western countries,
indicating high incidence of mastalgia in affected women,
especially before menstrual period.
The exact cause of cyclical mastalgia is poorly understood,
but based on our results and other similar ﬁndings, the link to the
menstrual cycle makes a hormonal connection likely. On the
other hand, the use of OCPs could effectively reduce pain and
discomfort severity in affected women. It has been demonstrated
that when breast pain occurs in women taking OCPs, it often
resolves after a few cycles [18,19]. In a randomized controlled
trial, of 1417 women comparing contraceptives, breast pain
was cited by 18% of those using transdermal therapy versus
5.8% of those using oral therapy, and was described by 85%
as mild-moderate in severity. A multi-institutional cross-sec-
tion prevalence study found that women receiving long-acting
parenteral progesterones for contraception were signiﬁcant less
breast pain than those of the control group. It is unclear whether
OCPs relieve or cause cyclic mastalgia [19].
Regarding psychological states, no discrepant was revealed
in experience of depression; however anxiety was slightly more
prevalent in mastalgia group. In fact, women with anxiety
background might suffer from mastalgia more than other
women. In a study by Shrestha and Sen [20], compared to women
without mastalgia, women with frequent mastalgia were more
likely to screen positive for major depression, panic disorder,
eating disorder, alcohol misuse, and domestic violence.
Another study [21], which compared several groups of women,
reported the high levels of mood disturbance in women with
severe mastalgia.
Most of women with breast discomfort suffer cyclical
mastalgia which severity can be determined by advanced age,
age of marriage, history of abortion and history of PMS, but
inversely by OCP use and exercise activity. Whether stress is a
result of the pain or a contributing factor, psychological
assessment and support is an integral part of the management
of mastalgia.
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